Procept BioRobotics’ $163.9 Million Initial Public Offering

Latham & Watkins represented PROCEPT in the transaction.PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now